Clinical Trial Update: Groups for Regaining Our Wellbeing (GROW) [Phase 2, Phase 3]

View source ↗

Summary

The GROW trial for post-traumatic stress disorder and depression (Phase 2/Phase 3) sponsored by the US Department of Veterans Affairs has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Post-traumatic Stress Disorder

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Posttraumatic Stress Disorder, Depression | Phase 2, Phase 3 | Status: WITHDRAWN